Top compounds associated with response to CLDN11


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.062 0.07
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.057 0.07
mRNA MG-132 CTRPv2 pan-cancer AAC -0.11 0.08
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.058 0.08
mRNA GDC-0449 FIMM pan-cancer AAC -0.31 0.08
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.056 0.08
mRNA CIL70 CTRPv2 pan-cancer AAC 0.084 0.08
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.1 0.08
mRNA BX-795 GDSC1000 pan-cancer AAC 0.061 0.08
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.08
Download CSV